Skip to main content
Premium Trial:

Request an Annual Quote

ABI s Decision to License Affy s Array IP Tops Most-Read GenomeWeb News Stories Last Week

NEW YORK, Dec. 27 (GenomeWeb News) - What are GenomeWeb News subscribers reading? Below are the five most-read articles for the five-day period ended Friday, Dec. 23.


1. ABI Licenses Affy Microarray Patents for Gene Expression Analysis (from Dec. 22)

2. Sequencing DNA of 27,000-Year-Old Woolly Mammoth, Researchers Point to New Field of 'Paleogenomics'  (from Dec. 20)

3. 454 Life Sciences Enters Research Collaboration with Broad Institute (from Dec. 19)

4. 454 and Solexa Pursued by Pack of Next-Gen Sequencing Shops; Competition to Heat up in 2006 (from Dec. 19)

5. Third Wave's ex-CEO Receives Severance; New VP at Orchid Cellmark; Others (from Dec. 21)

The Scan

Team Tracks Down Potential Blood Plasma Markers Linked to Heart Failure in Atrial Fibrillation Patients

Researchers in BMC Genomics found 10 differentially expressed proteins or metabolites that marked atrial fibrillation with heart failure cases.

Study Points to Synonymous Mutation Effects on E. Coli Enzyme Activity

Researchers in Nature Chemistry saw signs of enzyme activity shifts in the presence of synonymous mutations in a multiscale modeling analysis of three Escherichia coli genes.

Team Outlines Paternal Sample-Free Single-Gene Approach for Non-Invasive Prenatal Screening

With data for nearly 9,200 pregnant individuals, researchers in Genetics in Medicine demonstrate the feasibility of their carrier screening and reflex single-gene non-invasive prenatal screening approach.

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.